So just mostly because no ones looking at it, no ones investigating
Retatrutide (development code LY-3437943) is a synthetic peptide developed by Eli Lilly and Company designed to act simultaneously on three hormone-receptor pathways: GLP-1 (glucagonlike peptide-1) GIP (glucosedependent insulinotropic polypeptide) Glucagon receptor (GCG) nejm.org Put simply: it takes the mechanism of todays weight-loss injections and adds an extra dimension of hormonal stimulation, with the aim of significantly greater weight-loss outcomes
Personal Opinion: Having reviewed hundreds of case reports and clinical studies, I believe testosterone optimization represents the single most underutilized tool in mens metabolic health
Reconstitute lyophilized retatrutide with bacteriostatic water, directing the solvent against the vial wall at a 45-degree angle
Many people experience no symptoms until they reach a higher dose
These symptoms, while typically mild to moderate, can be severe enough to affect daily life